Publication | Open Access
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
336
Citations
11
References
2018
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1